Aphria (TSE:APH) had its target price hoisted by research analysts at Pi Financial from C$14.00 to C$25.00 in a report issued on Thursday, January 11th. Pi Financial’s price target would indicate a potential upside of 80.12% from the stock’s previous close.
Separately, Canaccord Genuity upped their target price on Aphria from C$8.25 to C$14.00 in a research note on Tuesday, December 5th.
Aphria (TSE APH) traded down C$1.60 on Thursday, hitting C$13.88. The stock had a trading volume of 8,663,900 shares, compared to its average volume of 5,710,000. The company has a market cap of $2,230.00, a price-to-earnings ratio of 81.65 and a beta of -0.68. Aphria has a 52-week low of C$4.55 and a 52-week high of C$24.75.
Aphria (TSE:APH) last announced its earnings results on Wednesday, January 10th. The company reported C$0.04 earnings per share (EPS) for the quarter. Aphria had a return on equity of 21.38% and a net margin of 245.74%.
TRADEMARK VIOLATION WARNING: “Aphria (TSE:APH) PT Raised to C$25.00” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/04/aphria-aph-price-target-raised-to-c25-00-at-pi-financial.html.
Aphria Inc produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.